Global Hyperimmune Globulins Market Research Report 2023(Status and Outlook)

Global Hyperimmune Globulins Market Research Report 2023(Status and Outlook)



Report Overview

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides ""passive"" immunity to the patient against an agent. This is in contrast to vaccines that provide ""active"" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant ""passive"" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides ""passive"" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%.

Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.

In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

The Global Hyperimmune Globulins Market Size was estimated at USD 1527.40 million in 2022 and is projected to reach USD 2452.67 million by 2029, exhibiting a CAGR of 7.00% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Hyperimmune Globulins market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hyperimmune Globulins Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hyperimmune Globulins market in any manner.

Global Hyperimmune Globulins Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

CSL Behring

Grifols

Biotest

Kedrion

CBPO

Emergent (Cangene)

Kamada

CNBG

Hualan Bio

Shanghai RAAS

Sichuan Yuanda Shuyang

ADMA Biologics

Market Segmentation (by Type)

Hepatitis B Immunoglobulins

Rabies Immunoglobulins

Tetanus Immunoglobulins

Rho(D) Immunoglobulins

Other

Market Segmentation (by Application)

Automobile Manufacturing

Precision Machinery

Electrical Equipment

Metal Products

Automobile Manufacturing

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Hyperimmune Globulins Market

Overview of the regional outlook of the Hyperimmune Globulins Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hyperimmune Globulins
1.2 Key Market Segments
1.2.1 Hyperimmune Globulins Segment by Type
1.2.2 Hyperimmune Globulins Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hyperimmune Globulins Market Overview
2.1 Global Market Overview
2.1.1 Global Hyperimmune Globulins Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Hyperimmune Globulins Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hyperimmune Globulins Market Competitive Landscape
3.1 Global Hyperimmune Globulins Sales by Manufacturers (2018-2023)
3.2 Global Hyperimmune Globulins Revenue Market Share by Manufacturers (2018-2023)
3.3 Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hyperimmune Globulins Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Hyperimmune Globulins Sales Sites, Area Served, Product Type
3.6 Hyperimmune Globulins Market Competitive Situation and Trends
3.6.1 Hyperimmune Globulins Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hyperimmune Globulins Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hyperimmune Globulins Industry Chain Analysis
4.1 Hyperimmune Globulins Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hyperimmune Globulins Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hyperimmune Globulins Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hyperimmune Globulins Sales Market Share by Type (2018-2023)
6.3 Global Hyperimmune Globulins Market Size Market Share by Type (2018-2023)
6.4 Global Hyperimmune Globulins Price by Type (2018-2023)
7 Hyperimmune Globulins Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hyperimmune Globulins Market Sales by Application (2018-2023)
7.3 Global Hyperimmune Globulins Market Size (M USD) by Application (2018-2023)
7.4 Global Hyperimmune Globulins Sales Growth Rate by Application (2018-2023)
8 Hyperimmune Globulins Market Segmentation by Region
8.1 Global Hyperimmune Globulins Sales by Region
8.1.1 Global Hyperimmune Globulins Sales by Region
8.1.2 Global Hyperimmune Globulins Sales Market Share by Region
8.2 North America
8.2.1 North America Hyperimmune Globulins Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hyperimmune Globulins Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hyperimmune Globulins Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hyperimmune Globulins Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hyperimmune Globulins Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 CSL Behring
9.1.1 CSL Behring Hyperimmune Globulins Basic Information
9.1.2 CSL Behring Hyperimmune Globulins Product Overview
9.1.3 CSL Behring Hyperimmune Globulins Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Hyperimmune Globulins SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 Grifols
9.2.1 Grifols Hyperimmune Globulins Basic Information
9.2.2 Grifols Hyperimmune Globulins Product Overview
9.2.3 Grifols Hyperimmune Globulins Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Hyperimmune Globulins SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Biotest
9.3.1 Biotest Hyperimmune Globulins Basic Information
9.3.2 Biotest Hyperimmune Globulins Product Overview
9.3.3 Biotest Hyperimmune Globulins Product Market Performance
9.3.4 Biotest Business Overview
9.3.5 Biotest Hyperimmune Globulins SWOT Analysis
9.3.6 Biotest Recent Developments
9.4 Kedrion
9.4.1 Kedrion Hyperimmune Globulins Basic Information
9.4.2 Kedrion Hyperimmune Globulins Product Overview
9.4.3 Kedrion Hyperimmune Globulins Product Market Performance
9.4.4 Kedrion Business Overview
9.4.5 Kedrion Hyperimmune Globulins SWOT Analysis
9.4.6 Kedrion Recent Developments
9.5 CBPO
9.5.1 CBPO Hyperimmune Globulins Basic Information
9.5.2 CBPO Hyperimmune Globulins Product Overview
9.5.3 CBPO Hyperimmune Globulins Product Market Performance
9.5.4 CBPO Business Overview
9.5.5 CBPO Hyperimmune Globulins SWOT Analysis
9.5.6 CBPO Recent Developments
9.6 Emergent (Cangene)
9.6.1 Emergent (Cangene) Hyperimmune Globulins Basic Information
9.6.2 Emergent (Cangene) Hyperimmune Globulins Product Overview
9.6.3 Emergent (Cangene) Hyperimmune Globulins Product Market Performance
9.6.4 Emergent (Cangene) Business Overview
9.6.5 Emergent (Cangene) Recent Developments
9.7 Kamada
9.7.1 Kamada Hyperimmune Globulins Basic Information
9.7.2 Kamada Hyperimmune Globulins Product Overview
9.7.3 Kamada Hyperimmune Globulins Product Market Performance
9.7.4 Kamada Business Overview
9.7.5 Kamada Recent Developments
9.8 CNBG
9.8.1 CNBG Hyperimmune Globulins Basic Information
9.8.2 CNBG Hyperimmune Globulins Product Overview
9.8.3 CNBG Hyperimmune Globulins Product Market Performance
9.8.4 CNBG Business Overview
9.8.5 CNBG Recent Developments
9.9 Hualan Bio
9.9.1 Hualan Bio Hyperimmune Globulins Basic Information
9.9.2 Hualan Bio Hyperimmune Globulins Product Overview
9.9.3 Hualan Bio Hyperimmune Globulins Product Market Performance
9.9.4 Hualan Bio Business Overview
9.9.5 Hualan Bio Recent Developments
9.10 Shanghai RAAS
9.10.1 Shanghai RAAS Hyperimmune Globulins Basic Information
9.10.2 Shanghai RAAS Hyperimmune Globulins Product Overview
9.10.3 Shanghai RAAS Hyperimmune Globulins Product Market Performance
9.10.4 Shanghai RAAS Business Overview
9.10.5 Shanghai RAAS Recent Developments
9.11 Sichuan Yuanda Shuyang
9.11.1 Sichuan Yuanda Shuyang Hyperimmune Globulins Basic Information
9.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Overview
9.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Market Performance
9.11.4 Sichuan Yuanda Shuyang Business Overview
9.11.5 Sichuan Yuanda Shuyang Recent Developments
9.12 ADMA Biologics
9.12.1 ADMA Biologics Hyperimmune Globulins Basic Information
9.12.2 ADMA Biologics Hyperimmune Globulins Product Overview
9.12.3 ADMA Biologics Hyperimmune Globulins Product Market Performance
9.12.4 ADMA Biologics Business Overview
9.12.5 ADMA Biologics Recent Developments
10 Hyperimmune Globulins Market Forecast by Region
10.1 Global Hyperimmune Globulins Market Size Forecast
10.2 Global Hyperimmune Globulins Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hyperimmune Globulins Market Size Forecast by Country
10.2.3 Asia Pacific Hyperimmune Globulins Market Size Forecast by Region
10.2.4 South America Hyperimmune Globulins Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hyperimmune Globulins by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Hyperimmune Globulins Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Hyperimmune Globulins by Type (2024-2029)
11.1.2 Global Hyperimmune Globulins Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Hyperimmune Globulins by Type (2024-2029)
11.2 Global Hyperimmune Globulins Market Forecast by Application (2024-2029)
11.2.1 Global Hyperimmune Globulins Sales (K MT) Forecast by Application
11.2.2 Global Hyperimmune Globulins Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings